Logotype for Medical Properties Trust Inc

Medical Properties Trust (MPT) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Medical Properties Trust Inc

Q4 2024 earnings summary

23 Dec, 2025

Executive summary

  • Completed $5.5 billion in asset monetization, including $3 billion in sales and a $2.5 billion secured notes offering, addressing all debt maturities through 2026 and strengthening liquidity.

  • Achieved a global settlement in Prospect Medical Holdings' bankruptcy, providing $25 million in funding and enabling asset sales, with proceeds primarily allocated to creditors, pending court approval.

  • Portfolio remains resilient and diversified, with 396 properties and 39,000 licensed beds across nine countries, and new operators ramping up.

  • Declared a regular quarterly dividend of $0.08 per share in February 2025, reduced from prior periods.

  • Positioned to pursue shareholder value initiatives in 2025 after addressing all debt maturities through 2026.

Financial highlights

  • Reported a GAAP net loss of $413 million for Q4 2024 and $2.4 billion for the full year; net loss per share was $0.69 for Q4 and $4.02 for the year.

  • Normalized FFO (NFFO) was $0.18 per share for Q4 and $0.80 per share for 2024, both down from prior year periods.

  • Q4 results included $415 million in impairments and fair value adjustments related to Prospect and PHP Holdings.

  • Revenues for 2024 were $995.5 million, up from $871.8 million in 2023.

  • Dividends declared per share: $0.08 for Q4 2024, $0.46 for full-year 2024, compared to $0.15 and $0.88, respectively, in 2023.

Outlook and guidance

  • Expect total annualized cash rent of over $1 billion once new tenants are fully ramped.

  • Contractual cash rent from re-tenanted facilities to ramp up to $40 million per quarter by October 2026, adding $0.06 per share.

  • Construction of two new hospitals in Massachusetts and Texas expected to generate $10 million in annual revenue upon completion.

  • Sufficient liquidity to satisfy debt obligations through October 2027, with flexibility for further asset sales or joint ventures.

  • Positioned to pursue a range of shareholder value initiatives in 2025 after addressing all debt maturities through 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more